Synthesis and Crystal Structure of (E)-2-(1-(2-Hydroxy-4-methoxyphenyl)ethylideneamino)-3-(4-hydroxyphenyl)methyl Propionate

(E)-2-(1-(2-Hydroxy-4-methoxyphenyl)ethylideneamino)-3-(4-hydroxyphenyl)methyl propionate (C22H27O6N, Mr = 401.45) has been synthesized by a condensation reaction of paeonol with tyrosin methyl ester hydrochloride, and its structure was determined by IR, NMR, HR MS and X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P21/c, with a = 11.91291(15), b = 9.49947(12), c = 19.8727(3) , β = 106.1104(15)°, V = 2160.60(5)3, Z = 4, Dc = 1.234 g/cm3, μ = 0.739 mm-1, F(000) = 856, R = 0.0466 and wR = 0.1461 for 3859 observed reflections with (Ⅰ> 2σ(Ⅰ)). In the crystal structure, the title compound is constructed by a centrosymmetric dimmer unit composed of a pair of π-π stacking enantiomers, and such units are linked by intermolecular O(5)-H(5)…O(1) and intramolecular N(1)-H(1)…O(1) hydrogen bonds.     

Synthesis and Crystal Structure of （5-Hydroxy-6-methoxybenzofuran- 3-yl）-（4-methoxyphenyl）methanone

Compound 1 (5-hydroxy-6-methoxybenzofuran-3-yl)(4-methoxyphenyl)methanone, C17H14O5 , as a potential anti-breast cancer agent has been synthesized under microwave irradiation, which was further converted to (5,6-dihydroxybenzofuran-3-yl)(4-methoxyphenyl)methanone (2). The compounds were characterized by MS and NMR spectra. Meanwhile, the crystal of 1 was obtained and determined by X-ray single-crystal diffraction. Crystal data: monoclinic system, space group P21/n, a=8.908(6), b=10.505(7), c=15.452(11), β=105.043(9)°, V=1396.4(16)3 , Z=4, F(000)=624, Dc=1.419 g/cm3 , μ=0.105 mm1, R=0.0513 and wR=0.1246 for 14459 independent reflections (Rint=0.0647) and 2488 observed ones (I>2σ(I)). Intermolecular O-H···O and π-π stacking interactions contributed to the stability of the structure.     

Nitration of 6-(4-methoxyphenyl)-3-oxocyclohexane-1,1,2,2- tetracarbonitriles and 5-Hydroxy-3-(4-methoxy-3-phenyl)-7-oxo- 6-azabicyclo[3.2.1]octane-1,2,2-tricarbonitriles

Russian Journal of General Chemistry -     

2-甲基-3-(4-对甲氧基苯基)-5-(3-甲氧基苯基)异噁唑啉及其生物活性

采用1,3-偶极环加成反应合成了2-甲基-3-对甲氧基苯基-5-间甲氧基苯基异噁唑啉,分离了顺、反异构体,采用核磁共振氢谱分析表征了顺反异构体的谱图行为,对异构体的生物活性进行了测定,新杀菌剂2-甲基-3-对甲氧基苯基-5-间甲氧基苯基异噁唑啉对病菌的有效成分为反式结构,顺式体为无效成分.     

新型1-(4-氨基苯基)-4-(4-甲氧基苯基)哌嗪衍生物的合成

以二乙醇胺为原料,经溴化、环合、N-烷基化和还原4步反应制得关键中间体——4-[4-(4-甲氧基苯基)哌嗪-1-基]苯胺(4);4与酰氯经酰基化反应合成了11个新型的1-(4-氨基苯基)-4-(4-甲氧基苯基)哌嗪衍生物,其结构经1H NMR,FT-IR,ESI-MS和元素分析表征。     

7-羟基-4-甲基-8-(4'-甲基哌嗪-1'-基)-亚甲基香豆素的光二聚行为

通过Mannich反应在7-羟基-4-甲基香豆素的8-位上引入具有pH响应性能的4-甲基哌嗪的供电子哌嗪基团, 得到水溶性香豆素衍生物, 7-羟基-4-甲基-8-(4'-甲基哌嗪-1'-基)-亚甲基香豆素(HMPC), 利用哌嗪环上的叔胺给电子体系对酸碱的敏感特性调节HMPC的光二聚反应特征. 详细考察该香豆素衍生物在不同pH水溶液中的紫外光二聚性能, 紫外光谱分析显示, 通过调节HMPC水溶液的酸碱性可有效改变其紫外特征吸收; 在波长大于310 nm的紫外光照射下, 衍生物上的香豆素单元可进行光二聚, 并且紫外点光源光二聚反应实验表明, 其在中性水溶液中的反应速度最快, 其次为碱性条件中的反应, 最慢的则是酸性条件中的反应.